News

Find News

Filter articles

Showing 1 to 10 of 1749 results

Texas universities sue J&J subsidiary over biodegradable fibres

US17-11-2017

A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

Eli Lilly refused injunction against Teva, Actavis and Mylan

UK17-11-2017

The English High Court has refused to grant Eli Lilly an injunction which would have stopped Teva, Actavis and Mylan marketing a generic version of its drug Cialis (tadalafil).

Federal Circuit approves PTAB victory for Bass

US16-11-2017

NPS Pharmaceuticals suffered a knock-back yesterday, when the US Court of Appeals for the Federal Circuit affirmed a decision which found that claims covering a patent owned by NPS were unpatentable. 

Bayer collaborates with Loxo Oncology on cancer medicine

US16-11-2017

Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.

Janssen drops biosimilar suit against Samsung

US15-11-2017

Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis.

Excision Bio licenses CRISPR technology from UC Berkeley

US15-11-2017

Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California, Berkeley for “newly discovered” CRISPR gene editors. 

Reasonable foresight required for second medical use infringement: Dutch Supreme Court

Netherlands14-11-2017

Swiss-type second medical use patents can be infringed if a generic producer could have reasonably foreseen that its product would be used intentionally for the claimed use, according to the Supreme Court of the Netherlands.

Federal Circuit reverses its earlier ruling in Life Technologies v Promega

US14-11-2017

The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement. 

Brazil launches system for accessing genetic heritage

Brazil14-11-2017

The National System for the Management of Genetic Heritage (SisGen) has been officially launched in Brazil.

Five testimonies from the Allergan-tribe patent hearing

US13-11-2017

On November 7, the House Judiciary Committee’s subcommittee on IP took part in the “Sovereign Immunity and the Intellectual Property System” hearing.

Showing 1 to 10 of 1749 results

LSIPR